A Novel Nonthermal Energy Source for Surgical Epicardial Atrial Ablation: Irreversible Electroporation
AbstractConclusions. We propose a new modality to perform atrial ablations, which holds the potential of providing very swift, precise, and complete transmurality with no local heating effects.
Abreu Filho CA, Lisboa LA, Dallan LA, et al. 2005. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation 112(suppl 9):I20-5.nAccord RE, van Suylen RJ, van Brakel TJ, Maessen JG. 2005. Postmortem histologic evaluation of microwave lesions after epicardial pulmonary vein isolation for atrial fibrillation. Ann Thorac Surg 80:881-7.nBarnett SD, Ad N. 2006. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg 131:1029-35.nCoster HG. 1965. Quantitative analysis of the voltage-current relationship of fixed charge membranes and the associated property of "punch-through". Biophys J 5:669-86.nCrowley JM. 1973. Electrical breakdown of biomolecular lipid membranes as an electromechanical instability. Biophys J 13:711-24.nCummings JE, Pacifico A, Drago JL, Kilicaslan F, Natale A. 2005. Alternative energy sources for the ablation of arrhythmias. Pacing Clin Electrophysiol 28:434-43.nDavalos RV, Mir LM, Rubinsky B. 2005. Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223-31.nDeneke T, Khargi K, Muller KM, et al. 2005. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J 26:1797-803.nDoll N, Borger MA, Fabricius A, et al. 2003. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc Surg 125:836-42.nEdd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. 2006. In-vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409-15.nFayad G, Modine T, Le Tourneau T, et al. 2003. Circumflex artery stenosis induced by intraoperative radiofrequency ablation. Ann Thorac Surg 76:1291-3.nGaynor SL, Byrd GD, Diodato MD, et al. 2006. Microwave ablation for atrial fibrillation: dose-response curves in the cardioplegia-arrested and beating heart. Ann Thorac Surg 81:72-6.nGehl J. 2003. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177:437-47.nMack CA, Milla F, Ko W, et al. 2005. Surgical treatment of atrial fibrillation using argon-based cryoablation during concomitant cardiac procedures. Circulation 112(suppl 9):I1-6.nManasse E, Medici D, Ghiselli S, Ornaghi D, Gallotti R. 2003. Left main coronary arterial lesion after microwave epicardial ablation. Ann Thorac Surg 76:276-7.nMelby SJ, Zierer A, Bailey MS, et al. 2006. A new era in the surgical treatment of atrial fibrillation: the impact of ablation technology and lesion set on procedural efficacy. Ann Surg 244:583-92.nMilla F, Skubas N, Briggs WM, et al. 2006. Epicardial beating heart cryoablation using a novel argon-based cryoclamp and linear probe. J Thorac Cardiovasc Surg 131:403-11.nMiller L, Leor J, Rubinsky B. 2005. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4:699-705.nMir LM, Belehradek M, Domenge C, et al. 1991. Electrochemotherapy, a novel antitumor treatment: first clinical trial. C R Acad Sci III 313:613-8.nNeumann E, Rosenheck K. 1972. Permeability changes induced by electric impulses in vesicular membranes. J Membr Biol 10:279-90.nNeumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. 1982. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841-5.nNinet J, Roques X, Seitelberger R, et al. 2005. Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. J Thorac Cardiovasc Surg 130:803-9.nRowan NJ, MacGregor SJ, Anderson JG, Fouracre RA, Farish O. 2000. Pulsed electric field inactivation of diarrhoeagenic Bacillus cereus through irreversible electroporation. Lett Appl Microbiol 31:110-4.nSantiago T, Melo J, Gouveia RH, et al. 2003. Epicardial radiofrequency applications: in vitro and in vivo studies on human atrial myocardium. Eur J Cardiothorac Surg 24:481-6.nThomas SP, Guy DJ, Boyd AC, et al. 2003. Comparison of epicardial and endocardial linear ablation using handheld probes. Ann Thorac Surg 75:543-8.nvan Brakel TJ, Bolotin G, Salleng KJ, et al. 2004. Evaluation of epicardial microwave ablation lesions: histology versus electrophysiology. Ann Thorac Surg 78:1397-402.nViola N, Williams MR, Oz MC, Ad N. 2002. The technology in use for the surgical ablation of atrial fibrillation. Semin Thorac Cardiovasc Surg 14:198-205.nWeaver JC. 2000. Electroporation of cells and tissues. IEEE Trans Plasma Sci 28:24-33.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).